Hemo Organic Ltd

Hemo Organic Ltd., a micro-cap trading and distribution company with a market capitalisation of just ₹7.00 crores, reported deeply troubling results for Q4 FY26 that underscore mounting existential challenges. The company posted a net loss of ₹0.51 crores in the March 2026 quarter, a dramatic reversal from a profit of ₹0.37 crores in the year-ago period. Revenue collapsed by 61.41% year-on-year to just ₹0.93 crores, whilst the company's balance sheet remains mired in negative net worth territory at ₹-0.15 crores.

Hemo Organic Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap trading and distribution company’s Mojo Score improved to 33.0, reflecting a cautiously optimistic outlook amid volatile market conditions and flat financial performance.

Hemo Organic Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 28 April 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The micro-cap trading and distribution company’s Mojo Score has declined to 23.0, signalling heightened risk for investors amid sideways technical trends and flat financial performance.

Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 21 Apr 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain under pressure. Investors should weigh the mildly bullish technical signals against the company’s persistent operational challenges and valuation concerns.

Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 16 Apr 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and challenging valuation metrics, signalling heightened risk for investors amid a volatile market backdrop.

Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges, prompting a reassessment of its risk and return profile by analysts.

Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 6 April 2026. This revision reflects a combination of deteriorating technical indicators, flat financial performance, and weak fundamental metrics, signalling heightened risk for investors amid challenging market conditions.

Hemo Organic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the latest insights into the company's performance and outlook.

Hemo Organic, a key player in the Trading & Distributors sector, has reached a significant milestone by touching a new 52-week high of Rs.22.51. This achievement reflects a sustained upward momentum, with the stock demonstrating robust performance over the past week and outperforming its sector peers.

Hemo Organic, a key player in the Trading & Distributors sector, reached a fresh 52-week high of Rs.21.44 today, reflecting a sustained rally that has captured market attention. The stock’s performance over recent sessions highlights notable momentum within a challenging broader market environment.

Hemo Organic, a key player in the Trading & Distributors sector, reached a new 52-week high today, touching Rs.20.42. This milestone reflects a sustained upward momentum, with the stock outperforming its sector and demonstrating robust price strength over recent sessions.

Hemo Organic, a key player in the Trading & Distributors sector, has reached a new 52-week high of Rs.19.45, reflecting a notable surge in its stock price. This milestone underscores the stock’s strong momentum over recent sessions amid broader market fluctuations.

Hemo Organic, a key player in the Trading & Distributors sector, reached a fresh 52-week high of Rs.18.53 today, underscoring a notable phase of momentum for the stock amid a mixed market environment.

Hemo Organic, a key player in the Trading & Distributors sector, reached a fresh 52-week high of Rs.17.65 today, reflecting notable momentum in its stock performance amid a broadly positive market environment.

Hemo Organic, a key player in the Trading & Distributors sector, reached a significant milestone today by touching a new 52-week high of Rs.15.25. This achievement underscores the stock’s strong momentum amid a mixed market environment.

Hemo Organic, a player in the Trading & Distributors sector, has reached a significant milestone by touching a new 52-week high of Rs.14.53 today, reflecting sustained momentum over the past week and notable outperformance relative to its sector peers.